Cytokine-mediated expansion does not deplete cord blood cells with stem cell characteristics

A. M. Rice, Jamie Case, M. R. Vowels

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cord blood (CB) has been successfully used to regenerate the hematopoietic system after myeloablative therapy. We investigated whether cytokine mediated expansion depletes CB of cells with stem cell characteristics. CB mononuclear cells (MNC) were enriched for quiescent (primitive) stem cells by incubation with 25 μg/ml 5-Fluorouracil (5-FU) and control CB MNC were incubated with media alone. Cells were then incubated for 7 days with interleukin-1 (IL1)+IL3+ Stem Cell Factor (SCF) and progenitor content, cell cycle status, nucleated cell count, immunophenotype and resistance to 25 μg/ml 5-FU (primitive stem cells) were evaluated before and after cytokine exposure. Incubation with IL1+IL3+SCF caused an increase (fold expansion) in committed (28.6 ± 8.1), immature (5.8 ± 1.8), and primitive progenitors (4.1 ± 0.8) among control CB MNC compared to a decrease in committed progenitors (0 ± 0) but an increase in both immature (8.4 ± 4.8) and primitive progenitors (7 ± 2.9) among 5-FU resistant CB MNC. An increase in the proportion of CD34+ cells occurred in both fractions. Expanded control CB MNC showed a significant increase in numbers of 5-FU resistant committed (p = 0.024), immature (p = 0.014) and primitive progenitors (p = 0.01) as compared with fresh CB MNC. Re-exposure of 5-FU resistant expanded CB MNC to 5-FU shows growth of some immature and primitive progenitors. Cytokine mediated expansion of untreated and quiescent CB cells is possible and cytokine-mediated expansion does not deplete CB cells with stem cell characteristics.

Original languageEnglish (US)
Pages (from-to)125-131
Number of pages7
JournalHematology and Cell Therapy
Volume39
Issue number3
DOIs
StatePublished - Jun 1997
Externally publishedYes

Fingerprint

Fetal Blood
Blood Cells
Stem Cells
Cytokines
Fluorouracil
Stem Cell Factor
Interleukin-1
Hematopoietic System
Cell Cycle
Cell Count

Keywords

  • Cord blood
  • Cytokine-mediated expansion
  • Progenitor cells
  • Stem cells

ASJC Scopus subject areas

  • Hematology

Cite this

Cytokine-mediated expansion does not deplete cord blood cells with stem cell characteristics. / Rice, A. M.; Case, Jamie; Vowels, M. R.

In: Hematology and Cell Therapy, Vol. 39, No. 3, 06.1997, p. 125-131.

Research output: Contribution to journalArticle

@article{a303287dac9249b885e230214430c801,
title = "Cytokine-mediated expansion does not deplete cord blood cells with stem cell characteristics",
abstract = "Cord blood (CB) has been successfully used to regenerate the hematopoietic system after myeloablative therapy. We investigated whether cytokine mediated expansion depletes CB of cells with stem cell characteristics. CB mononuclear cells (MNC) were enriched for quiescent (primitive) stem cells by incubation with 25 μg/ml 5-Fluorouracil (5-FU) and control CB MNC were incubated with media alone. Cells were then incubated for 7 days with interleukin-1 (IL1)+IL3+ Stem Cell Factor (SCF) and progenitor content, cell cycle status, nucleated cell count, immunophenotype and resistance to 25 μg/ml 5-FU (primitive stem cells) were evaluated before and after cytokine exposure. Incubation with IL1+IL3+SCF caused an increase (fold expansion) in committed (28.6 ± 8.1), immature (5.8 ± 1.8), and primitive progenitors (4.1 ± 0.8) among control CB MNC compared to a decrease in committed progenitors (0 ± 0) but an increase in both immature (8.4 ± 4.8) and primitive progenitors (7 ± 2.9) among 5-FU resistant CB MNC. An increase in the proportion of CD34+ cells occurred in both fractions. Expanded control CB MNC showed a significant increase in numbers of 5-FU resistant committed (p = 0.024), immature (p = 0.014) and primitive progenitors (p = 0.01) as compared with fresh CB MNC. Re-exposure of 5-FU resistant expanded CB MNC to 5-FU shows growth of some immature and primitive progenitors. Cytokine mediated expansion of untreated and quiescent CB cells is possible and cytokine-mediated expansion does not deplete CB cells with stem cell characteristics.",
keywords = "Cord blood, Cytokine-mediated expansion, Progenitor cells, Stem cells",
author = "Rice, {A. M.} and Jamie Case and Vowels, {M. R.}",
year = "1997",
month = "6",
doi = "10.1007/s00282-997-0125-1",
language = "English (US)",
volume = "39",
pages = "125--131",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Cytokine-mediated expansion does not deplete cord blood cells with stem cell characteristics

AU - Rice, A. M.

AU - Case, Jamie

AU - Vowels, M. R.

PY - 1997/6

Y1 - 1997/6

N2 - Cord blood (CB) has been successfully used to regenerate the hematopoietic system after myeloablative therapy. We investigated whether cytokine mediated expansion depletes CB of cells with stem cell characteristics. CB mononuclear cells (MNC) were enriched for quiescent (primitive) stem cells by incubation with 25 μg/ml 5-Fluorouracil (5-FU) and control CB MNC were incubated with media alone. Cells were then incubated for 7 days with interleukin-1 (IL1)+IL3+ Stem Cell Factor (SCF) and progenitor content, cell cycle status, nucleated cell count, immunophenotype and resistance to 25 μg/ml 5-FU (primitive stem cells) were evaluated before and after cytokine exposure. Incubation with IL1+IL3+SCF caused an increase (fold expansion) in committed (28.6 ± 8.1), immature (5.8 ± 1.8), and primitive progenitors (4.1 ± 0.8) among control CB MNC compared to a decrease in committed progenitors (0 ± 0) but an increase in both immature (8.4 ± 4.8) and primitive progenitors (7 ± 2.9) among 5-FU resistant CB MNC. An increase in the proportion of CD34+ cells occurred in both fractions. Expanded control CB MNC showed a significant increase in numbers of 5-FU resistant committed (p = 0.024), immature (p = 0.014) and primitive progenitors (p = 0.01) as compared with fresh CB MNC. Re-exposure of 5-FU resistant expanded CB MNC to 5-FU shows growth of some immature and primitive progenitors. Cytokine mediated expansion of untreated and quiescent CB cells is possible and cytokine-mediated expansion does not deplete CB cells with stem cell characteristics.

AB - Cord blood (CB) has been successfully used to regenerate the hematopoietic system after myeloablative therapy. We investigated whether cytokine mediated expansion depletes CB of cells with stem cell characteristics. CB mononuclear cells (MNC) were enriched for quiescent (primitive) stem cells by incubation with 25 μg/ml 5-Fluorouracil (5-FU) and control CB MNC were incubated with media alone. Cells were then incubated for 7 days with interleukin-1 (IL1)+IL3+ Stem Cell Factor (SCF) and progenitor content, cell cycle status, nucleated cell count, immunophenotype and resistance to 25 μg/ml 5-FU (primitive stem cells) were evaluated before and after cytokine exposure. Incubation with IL1+IL3+SCF caused an increase (fold expansion) in committed (28.6 ± 8.1), immature (5.8 ± 1.8), and primitive progenitors (4.1 ± 0.8) among control CB MNC compared to a decrease in committed progenitors (0 ± 0) but an increase in both immature (8.4 ± 4.8) and primitive progenitors (7 ± 2.9) among 5-FU resistant CB MNC. An increase in the proportion of CD34+ cells occurred in both fractions. Expanded control CB MNC showed a significant increase in numbers of 5-FU resistant committed (p = 0.024), immature (p = 0.014) and primitive progenitors (p = 0.01) as compared with fresh CB MNC. Re-exposure of 5-FU resistant expanded CB MNC to 5-FU shows growth of some immature and primitive progenitors. Cytokine mediated expansion of untreated and quiescent CB cells is possible and cytokine-mediated expansion does not deplete CB cells with stem cell characteristics.

KW - Cord blood

KW - Cytokine-mediated expansion

KW - Progenitor cells

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=0030750567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030750567&partnerID=8YFLogxK

U2 - 10.1007/s00282-997-0125-1

DO - 10.1007/s00282-997-0125-1

M3 - Article

C2 - 9262988

AN - SCOPUS:0030750567

VL - 39

SP - 125

EP - 131

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 3

ER -